Tandem Diabetes Care Receivables 2012-2024 | TNDM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Tandem Diabetes Care receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Tandem Diabetes Care receivables from 2012 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$196.3B
Intuitive Surgical (ISRG)	$195.1B
Alcon (ALC)	$42.4B
Edwards Lifesciences (EW)	$41.6B
IQVIA Holdings (IQV)	$36.6B
IDEXX Laboratories (IDXX)	$34.2B
DexCom (DXCM)	$28.4B
Waters (WAT)	$22.2B
STERIS (STE)	$21.2B
SONOVA HOLDING (SONVY)	$20.8B
Hologic (HOLX)	$18.3B
Fresenius Medical Care AG KGaA (FMS)	$13B
Sysmex ADR (SSMXY)	$12.9B
Globus Medical (GMED)	$11.5B
Penumbra (PEN)	$9.4B
Masimo (MASI)	$9.3B
Teleflex (TFX)	$8.9B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$4.9B
Integer Holdings (ITGR)	$4.6B
Veracyte (VCYT)	$3.1B
Inari Medical (NARI)	$2.9B
LivaNova (LIVN)	$2.8B
TransMedics (TMDX)	$2.6B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.2B
Integra LifeSciences Holdings (IART)	$1.8B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.4B
Artivion (AORT)	$1.2B